Search...
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
I'm PortAI, I can summarize articles.
Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating the proposed sale of Mersana Therapeutics, Inc. to Day One Biopharmaceuticals, Inc. The investigation focuses on the adequacy of the $25 per share cash offer and potential milestone payments, totaling up to $55.25 per share. Shareholders are encouraged to contact KSF if they believe the transaction undervalues the company.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments